157 related articles for article (PubMed ID: 30483359)
1. High tumour burden, delayed diagnosis and history of cardiovascular disease may be associated with carcinoid heart disease.
Alves C; Mesquita M; Silva C; Soeiro M; Hajjar L; Riechelmann RP
Ecancermedicalscience; 2018; 12():879. PubMed ID: 30483359
[TBL] [Abstract][Full Text] [Related]
2. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours.
Kostiainen I; Karppinen N; Simonen P; Rosengård-Bärlund M; Lindén R; Tarkkanen M; Gordin D; Rapola J; Schalin-Jäntti C; Matikainen N
Endocrine; 2022 Jun; 77(1):177-187. PubMed ID: 35536452
[TBL] [Abstract][Full Text] [Related]
3. Carcinoid heart disease in patients with midgut neuroendocrine tumours.
Delhomme C; Walter T; Arangalage D; Suc G; Hentic O; Cachier A; Alkhoder S; François L; Lombard-Bohas C; Iung B; Ruszniewski P; de Mestier L
J Neuroendocrinol; 2023 Apr; 35(4):e13262. PubMed ID: 37005217
[TBL] [Abstract][Full Text] [Related]
4. Carcinoid Heart Disease and Decreased Overall Survival among Patients with Neuroendocrine Tumors: A Retrospective Multicenter Latin American Cohort Study.
Uema D; Alves C; Mesquita M; Nuñez JE; Siepmann T; Angel M; Rego JFM; Weschenfelder R; Rocha Filho DR; Costa FP; Barros M; O'Connor JM; Illigens BM; Riechelmann RP
J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30909590
[TBL] [Abstract][Full Text] [Related]
5. Real-world treatment patterns, resource use and costs of treating uncontrolled carcinoid syndrome and carcinoid heart disease: a retrospective Swedish study.
Lesén E; Björstad Å; Björholt I; Marlow T; Bollano E; Feuilly M; Marteau F; Welin S; Elf AK; Johanson V
Scand J Gastroenterol; 2018 Dec; 53(12):1509-1518. PubMed ID: 30449217
[TBL] [Abstract][Full Text] [Related]
6. First Case of Regression of Carcinoid Heart Disease on Serial Transthoracic Echocardiograms following Octreotide Monotherapy in a Patient with Metastatic Pancreatic Neuroendocrine Tumor.
Nath E; Sawyer MB; Choy J
Case Rep Oncol; 2020; 13(3):1454-1462. PubMed ID: 33442370
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary team management of carcinoid heart disease.
Steeds R; Sagar V; Shetty S; Oelofse T; Singh H; Ahmad R; Bradley E; Moore R; Vickrage S; Smith S; Yim I; Elhassan YS; Venkataraman H; Ayuk J; Rooney S; Shah T
Endocr Connect; 2019 Dec; 8(12):R184-R199. PubMed ID: 31751305
[TBL] [Abstract][Full Text] [Related]
8. Health resource utilisation by patients with neuroendocrine tumours with or without carcinoid heart disease: a multinational study.
Tanaka H; Uema D; Rego JFM; Weschenfelder RF; D'Agustini N; Filho DRR; O'Connor JM; Luca R; Nuñez JER; de Barros E Silva MJ; Riechelmann RP
Ecancermedicalscience; 2020; 14():1141. PubMed ID: 33343700
[TBL] [Abstract][Full Text] [Related]
9. Metastatic well differentiated serotonin-producing pancreatic neuroendocrine tumor with carcinoid heart disease: a case report.
Kudelka MR; Abou-Alfa GK; O'Reilly EM; Foote MB; Sirohi B; Elias R; Shamseddine A; Paroder V; Moussa AM; Cohen P; Ganesh K
J Gastrointest Oncol; 2023 Aug; 14(4):1878-1886. PubMed ID: 37720425
[TBL] [Abstract][Full Text] [Related]
10. Carcinoid Heart Disease: Prognostic Value of 5-Hydroxyindoleacetic Acid Levels and Impact on Survival: A Systematic Literature Review.
Buchanan-Hughes A; Pashley A; Feuilly M; Marteau F; Pritchard DM; Singh S
Neuroendocrinology; 2021; 111(1-2):1-15. PubMed ID: 32097914
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, one-year-incidence and predictors of carcinoid heart disease.
Mattig I; Franke MR; Pschowski R; Brand A; Stangl K; Knebel F; Dreger H
Cardiovasc Ultrasound; 2023 Sep; 21(1):18. PubMed ID: 37752548
[TBL] [Abstract][Full Text] [Related]
12. Urinary 5-Hydroxyindolacetic Acid Measurements in Patients with Neuroendocrine Tumor-Related Carcinoid Syndrome: State of the Art.
Rossi RE; Lavezzi E; Jaafar S; Cristofolini G; Laffi A; Nappo G; Carrara S; Bertuzzi AF; Uccella S; Repici A; Zerbi A; Lania AGA
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627093
[TBL] [Abstract][Full Text] [Related]
13. Management and outcomes of carcinoid heart disease with liver metastases of midgut neuroendocrine tumours.
Suc G; Cachier A; Hentic O; Bazire B; Sannier A; Delhomme C; Nataf P; Laschet J; Deschamps L; Garbarz E; Ou P; Caligiuri G; Iung B; Ruszniewski P; de Mestier L; Arangalage D
Heart; 2023 Dec; 110(2):132-139. PubMed ID: 37463732
[TBL] [Abstract][Full Text] [Related]
14. Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease.
Zuetenhorst JM; Korse CM; Bonfrer JM; Bakker RH; Taal BG
Br J Cancer; 2004 Jun; 90(11):2073-9. PubMed ID: 15150565
[TBL] [Abstract][Full Text] [Related]
15. Mesenteric Fibrosis in Midgut Neuroendocrine Tumors: Functionality and Radiological Features.
Rodríguez Laval V; Pavel M; Steffen IG; Baur AD; Dilz LM; Fischer C; Detjen K; Prasad V; Pascher A; Geisel D; Denecke T
Neuroendocrinology; 2018; 106(2):139-147. PubMed ID: 28384635
[TBL] [Abstract][Full Text] [Related]
16. Incidence and evolution of carcinoid syndrome in the heart.
Moyssakis IE; Rallidis LS; Guida GF; Nihoyannopoulos PI
J Heart Valve Dis; 1997 Nov; 6(6):625-30. PubMed ID: 9427132
[TBL] [Abstract][Full Text] [Related]
17. Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor.
Zuetenhorst JM; Bonfrer JM; Korse CM; Bakker R; van Tinteren H; Taal BG
Cancer; 2003 Apr; 97(7):1609-15. PubMed ID: 12655516
[TBL] [Abstract][Full Text] [Related]
18. Activin A in carcinoid heart disease: a possible role in diagnosis and pathogenesis.
Bergestuen DS; Edvardsen T; Aakhus S; Ueland T; Oie E; Vatn M; Aukrust P; Thiis-Evensen E
Neuroendocrinology; 2010; 92(3):168-77. PubMed ID: 20720391
[TBL] [Abstract][Full Text] [Related]
19. The path to surgery in carcinoid heart disease: a retrospective study and a multidisciplinary proposal of a new algorithm.
Mortelmans P; Herregods MC; Rega F; Timmermans P
Acta Cardiol; 2019 Jun; 74(3):207-214. PubMed ID: 29914291
[No Abstract] [Full Text] [Related]
20. Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study.
Halperin DM; Shen C; Dasari A; Xu Y; Chu Y; Zhou S; Shih YT; Yao JC
Lancet Oncol; 2017 Apr; 18(4):525-534. PubMed ID: 28238592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
